A marked increase of radio-sensitivity in human NSCLC cell lines often occurs after inhibiting survivin expression with YM155 (sepantronium bromide), a specific survivin inhibitor [33]. This evidence concerns the gene BIRC5 and non-small cell lung carcinoma.